The outcome of a Canada-led international trial has inspired scientists to suggest radiotherapy as standard treatment for men living with higher risk of terrible prostate cancer. During the study, it was observed that the blend of radiotherapy and traditional hormonal treatment has potential to minimize the number of deaths caused by prostate cancer.

While commenting on the findings, the Chief Executive of the Prostate Cancer Charity, Owen Sharp marked it as very first research that that has attempted to explore the benefits. "Although we are seeing this treatment combination already being used in practice in some pockets across the country, we now need to urgently see this become more standard clinical practice”, Owen Sharp added.

Before suggesting the findings, the experts analyzed more than 1,200 individuals suffering from "high risk" prostate cancer developed beyond the gland, but has not affected the rest body parts. The experts have grouped the subjects into two categories. Afterwards, they treated one group with standard hormonal therapy whereas another with radiation plus hormone therapy.

Prostate cancer is a deadly form of cancer that affects a huge population across the world. As per available medical reports, more than 25,500 men in Canada are likely to suffer prostate cancer every year, while several are prone to death.

The lead study author, Dr. Padraig Warde explained the research findings and expressed confidence that they will play a significant role to minimize the number of disease related deaths. At present, Dr. Padraig Warde is offering his services as a Deputy Head of the radiation medicine program at Princess Margaret Hospital situated in Toronto.

Experts have notified that and rogen deprivation therapy aims testosterone and drags its measure to almost zero with the help of castration, a procedure that involves removal of the testicles.